Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.

Asian Pacific journal of cancer prevention : APJCP - 1 May 2020

Rahimi Nahid, Azizi Mahsa, Bahari Gholamreza, Narouie Behzad, Hashemi Mohammad

Abstract excerpt

Several studies have evaluated the association between EGLN2 4-bp insertion/deletion (ins/del) polymorphism (rs10680577) and many cancers. However, up to date, no study has inspected the impact of rs10680577 polymorphism on prostate cancer (PCa) risk. This case-control study was achieved on 170 pathologically confirmed PCa patients and 196 cancer free men to inspect whether rs10680577 variant is related to the...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Case-Control Studies
Share to Follow-Up Studies
Share to Hypoxia-Inducible Factor-Proline Dioxygenases
Share to Prognosis
Share to Promoter Regions, Genetic
Share to Prostatic Neoplasms
Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 32458625
DOI: 10.31557/APJCP.2020.21.5.1221
PMCID: PMC7541883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.PMID 32458625Read ↗

Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.Semantic proximity Read ↗

A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.Semantic proximity Read ↗

An insertion/deletion polymorphism within the promoter of EGLN2 is associated with susceptibility to colorectal cancer.Semantic proximity Read ↗

Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.Semantic proximity Read ↗

Association between the 8473T>C polymorphism of PTGS2 and prostate cancer risk: a metaanalysis including 24,716 subjects.Semantic proximity Read ↗

Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis.Semantic proximity Read ↗

Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.Semantic proximity Read ↗

Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.Semantic proximity Read ↗

Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.Semantic proximity Read ↗

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.Semantic proximity Read ↗

Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis.Semantic proximity Read ↗

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.